| (19) |
 |
|
(11) |
EP 1 609 476 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
published in accordance with Art. 158(3) EPC |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
| (48) |
Corrigendum issued on: |
|
12.04.2006 Bulletin 2006/15 |
| (43) |
Date of publication: |
|
28.12.2005 Bulletin 2005/52 |
| (22) |
Date of filing: 04.03.2004 |
|
| (51) |
International Patent Classification (IPC):
|
| (86) |
International application number: |
|
PCT/JP2004/002706 |
| (87) |
International publication number: |
|
WO 2004/078191 (16.09.2004 Gazette 2004/38) |
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
|
| (30) |
Priority: |
05.03.2003 JP 2003059056
|
| (71) |
Applicant: Original Image Co., Ltd. |
|
Yokohama-shi
Kanagawa 231-0004 (JP) |
|
| (72) |
Inventors: |
|
- YOSHIDA, Satoshi
Itabashi-ku, Tokyo 175-0082 (JP)
- KANEKO, Shuichi,
Kanazawa University Hospital
Kanazawa-shi,
Ishikawa 9208641 (JP)
|
| (74) |
Representative: HOFFMANN EITLE |
|
Patent- und Rechtsanwälte
Arabellastrasse 4
D-81925 München
D-81925 München (DE) |
|
| |
|
| (54) |
COMPOSITION FOR TREATING HEPATITIS C |
(57) By administering a composition comprising pumpkin seed, safflower, plantain and honeysuckle,
subjective symptoms (for example, general malaise and abdominal swelling) of a patient
with chronic hepatitis C can be eliminated and, moreover, objective symptoms diagnosed
by a medical doctor (for example, liver enlargement and palm erythema) can be relieved
or eliminated. From 1 to 3 months after the administration of the composition, a significant
decrease in hepatitis C virus RNA level is gradually observed. Therefore, the above
composition is useful at least as a composition for treating chronic hepatitis C.
In particular, it is advantageous in treating a chronic hepatitis C patient showing
a high chronic hepatitis C virus RNA level.